Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M. G. Teymurazov"'
Publikováno v:
Бюллетень сибирской медицины, Vol 20, Iss 2, Pp 95-101 (2021)
The aim of the study was to evaluate the immunoregulatory activity of an experimental drug based on ultra-high dilutions of antibodies to MHC I and MHC II molecules against Salmonella enteritidis rif92.Materials and methods. The drug tested: a sample
Externí odkaz:
https://doaj.org/article/c7513359aac2450c876fffb90ef67dcf
Autor:
E. A. Svetoch, A. I. Borzilov, B. V. Eruslanov, O. V. Korobova, T. I. Kombarova, V. P. Levchuk, M. G. Teymurazov, Y. G. Stepanshin, L. I. Marinin, I. A. Dyatlov
Publikováno v:
Антибиотики и Химиотерапия, Vol 56, Iss 9-10, Pp 13-18 (2020)
The therapeutic efficacy of enterocin S760, a broad spectrum antimicrobial peptide produced by Enterococcus faecium LWP760 was tested on mice infected with Bacillus anthracis M-71 to induce anthrax (second Tsenkovsky's vaccine). Intraperitoneal four-
Externí odkaz:
https://doaj.org/article/460265bcb27047e4b683a0599df1acc7
Autor:
E. A. Svetoch, M. G. Teymurazov, O. I. Tazina, A. A. Abaimova, A. I. Lev, E. I. Astashkin, E. S. Leonova, N. N. Kartsev, K. V. Detushev, B. V. Eruslanov, I. A. Dyatlov, N. K. Fursova
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 45, Iss 2, Pp 138-146 (2017)
Rationale: Enterococci are the leading cause of a number of nosocomial and community-acquired human diseases. In the last decade, these pathogens are becoming resistant to antibacterials, including vancomycin. Multidrug-resistant enterococci have bee
Externí odkaz:
https://doaj.org/article/a2f4da33fadb465fbedb358e1a6db165